Nanoformulation and Preclinical Evaluation of Dihydroartemisinin–Lumefantrine and Primaquine as Combined Antimalarial Therapy
The World Health Organization recommends artemisinin-based combinations for uncomplicated malaria treatment. Artemether and lumefantrine (LUM) are the first-line treatments, with artemether serving as a prodrug of dihydroartemisinin (DHA), while primaquine (PQ) is primarily used as a prophylactic dr...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of Nanotechnology |
| Online Access: | http://dx.doi.org/10.1155/jnt/5162847 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|